Welcome
Support Centre
19 March 2010 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A Randomised Trial Comparing External Beam Radiotherapy Alone With External Beam Radiotherapy Plus Intraluminal Irradiation for Palliation in Lung Cancer
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN83218866
Date ISRCTN assigned19/08/2002
Local reference number(s)ILT-2
Public titleA Randomised Trial Comparing External Beam Radiotherapy Alone With External Beam Radiotherapy Plus Intraluminal Irradiation for Palliation in Lung Cancer
Scientific title
AcronymNot Applicable
Disease/condition/study domainLung (non-small cell)
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Biopsy proven non-small cell lung cancer
2. Fit to receive bronchoscopy
3. Fit to receive external beam radiotherapy
4. Any age
5. Shortness of breath, cough, haemoptysis, dysphagia or chest pain resulting from a primary bronchial tumour
6. No previous or concomitant malignancy, except basal cell carcinomas
7. No symptomatic metastases requiring external beam radiotherapy
8. No previous chest irradiation for lung cancer
9. No bilateral lung tumours or tracheal tumours
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Status of trialCompleted
Target number of participantsNot provided at time of registration
Interventions1. Schedule A: External beam radiotherapy, a maximum subcutaneous dose of 3250 cGy given in eight fractions over 10 days with a margin of 2 cm around the tumour.

2. Schedule B: External beam radiotherapy, a maximum subcutaneous dose of 3250 cGy given in eight fractions over 10 days with a margin of 2 cm around the tumour. Followed by intraluminal radiotherapy, a single dose of 1500 cGy to be given on the last day of external beam radiotherapy.
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingNot available
Sponsor nameUK Co-ordinating Committee for Cancer Research (UKCCCR)
Sponsor detailsMRC Clinical Trials Unit
222 Euston Road
London
United Kingdom
NW1 2DA
Sponsor telephone+44 (0) 20 7670 4723
Sponsor fax+44 (0) 20 7670 4818
Sponsor emailregister@ctu.mrc.ac.uk
Sponsor websitehttp://www.ctu.mrc.ac.uk/ukcccr/home.html
Contact nameDr - -
Contact detailsUKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
United Kingdom
NW1 2DA
Contact telephone+44 (0) 20 7670 4723
Contact fax+44 (0) 20 7670 4818
Contact emailregister@ctu.mrc.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN83218866
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
terms & conditions | privacy statement | © Current Controlled Trials Ltd. Part of Springer Science+Business Media.


BioMed Central